OUTLOOK THERAPEUTICS INC (OTLK)

Name: OUTLOOK THERAPEUTICS INC (OTLK) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: OUTLOOK THERAPEUTICS INC (OTLK)

Stock Card

$0.67

$0.02 (2.70%)

As on 04-Sep-2026 16:27EDT

Market cap

$162 Mln

Revenue (TTM)

$-1 Mln

P/E Ratio

P/B Ratio

38.4

Div. Yield

0 %

OUTLOOK THERAPEUTICS INC (OTLK) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.65 High: 0.70

52 Week Range

Low: 0.16 High: 2.54

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-4.1
Debt to Equity

0
Book Value

$-0.1
EPS

$-2.4
Face value

--
Shares outstanding

242,672,554

10 Years Aggregate

CFO

$-346.51 Mln

EBITDA

$-386.46 Mln

Net Profit

$-447.38 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
OUTLOOK THERAPEUTICS INC (OTLK)	-57.8	-27.0	-17.7	-25.1	-47.2	-58.2	-50.5
BSE Sensex	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
OUTLOOK THERAPEUTICS INC (OTLK)	-16.4	-75.7	-63.5	-20.6	4.6	120.3	-85.3
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
OUTLOOK THERAPEUTICS INC (OTLK)	0.7	161.7	-1.2	-61.1	5,357.0	--	--	38.4
Arrowhead Pharmaceuticals (ARWR)	86.3	12,161.6	669.5	-320.0	-0.8	-71.1	--	26.2
Ascendis Pharma A/S - ADR	270.6	17,746.8	1,054.4	755.9	5.7	--	20.9	10.5
Cytokinetics Inc (CYTK)	72.7	10,109.8	71.0	-894.0	-1,175.8	--	--	60.5
Exelixis (EXEL)	59.0	14,621.6	2,435.9	860.6	31.0	43	18.6	7.9
Halozyme Therapeutics (HALO)	110.2	12,506.3	1,663.7	413.6	36.3	430	32.3	86.7
Krystal Biotech (KRYS)	358.2	10,603.5	440.5	241.5	33.4	18.7	44.9	8.1
Kymera Therapeutics (KYMR)	117.4	9,761.1	105.0	-299.7	-227.2	-19.4	--	6.5
Madrigal Pharmaceuticals (MDGL)	541.1	12,501.2	1,283.9	-325.1	-19.0	-57.7	--	23.9
Medpace Holdings (MEDP)	591.3	16,503.9	2,782.3	491.5	21.1	110.1	34.7	38.2

Shareholding Pattern

View Details

About OUTLOOK THERAPEUTICS INC (OTLK)

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product... formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Read more

Independent Executive Chairman

Mr. Ralph H. Thurman
Independent Executive Chairman

Mr. Ralph H. Thurman
Headquarters

Iselin, NJ
Website

https://outlooktherapeutics.com

FAQs for OUTLOOK THERAPEUTICS INC (OTLK)

What is the current share price of OUTLOOK THERAPEUTICS INC (OTLK) Today?

The share price of OUTLOOK THERAPEUTICS INC (OTLK) is $0.67 (NASDAQ) as of 04-Sep-2026 16:27 EDT. OUTLOOK THERAPEUTICS INC (OTLK) has given a return of -47.18% in the last 3 years.

What is the current PB & PE ratio of OUTLOOK THERAPEUTICS INC (OTLK)?

Since, TTM earnings of OUTLOOK THERAPEUTICS INC (OTLK) is negative, P/E ratio is not available.
The P/B ratio of OUTLOOK THERAPEUTICS INC (OTLK) is 38.42 times as on 04-Sep-2026, a 621 premium to its peers’ median range of 5.33 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-0.43	-0.84
2024	-1.31	-1.36
2023	-0.05	-0.20
2022	-0.20	1.48
2021	-0.34	3.97

What is the 52 Week High and Low of OUTLOOK THERAPEUTICS INC (OTLK)?

The 52-week high and low of OUTLOOK THERAPEUTICS INC (OTLK) are Rs 2.54 and Rs 0.16 as of 07-Sep-2026.

What is the market cap of OUTLOOK THERAPEUTICS INC (OTLK)?

OUTLOOK THERAPEUTICS INC (OTLK) has a market capitalisation of $ 162 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in OUTLOOK THERAPEUTICS INC (OTLK)?

Before investing in OUTLOOK THERAPEUTICS INC (OTLK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.